Evaluation of the clinical efficiency of tocilizumab versus rituximab therapy in patients with rheumatoid arthritis

Evaluation of the clinical efficiency of tocilizumab versus rituximab therapy in patients with rheumatoid arthritis

Objective: to evaluate the clinical efficiency of tocilizumab (TCZ) versus rituximab (RTM) therapy using DAS 28, SDAI, and CDAI scores and to estimate remission rates using DAS 28 and the remission criteria proposed by the European League Against Rheumatism (EULAR) and the American College of Rheuma...

Full description

Bibliographic Details
Main Authors: Anastasia Sergeyevna Avdeyeva, E N Aleksandrova, E Yu Panasyuk, G V Lukina, E L Nasonov
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2012-08-01
Series:Научно-практическая ревматология
Subjects:
das 28
sdai
cdai
rheumatoid arthritis
tocilizumab
rituximab
remission
Online Access:https://rsp.mediar-press.net/rsp/article/view/1032

Internet

https://rsp.mediar-press.net/rsp/article/view/1032

Similar Items